Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:focus |
gptkb:immunotherapy
cancer vaccines |
| gptkbp:foundedYear |
2006
|
| gptkbp:founder |
gptkb:Darren_E._Higgins
Kenneth B. Lichtenstein Robert L. Tepper William R. Clark |
| gptkbp:fullName |
Genocea Biosciences, Inc.
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:GEN-011
GEN-009 |
| gptkbp:status |
filed for bankruptcy in 2022
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:GNCA
|
| gptkbp:bfsParent |
gptkb:Genocea_Biosciences
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
GNCA
|